Our Management Team

Image

Alan Raffensperger

Chief Executive Officer

Image

Kay-Christian Karstadt

Chief Operating Officer

Image

Mark Corbett

Executive Vice President,
Medicines Access

Image

Peter Reichart

Executive Director Corporate Development

Image

Stefan Fraenkel

Executive Vice President, Commercial Products & Services

Image

Alan Raffensperger

Chief Executive Officer

Alan Raffensperger is the new Chief Executive Officer of Inceptua SA and its affiliates. Alan comes to Inceptua from Sobi (Swedish Orphan Biovitrum) where he was Chief Operating Officer since the start of 2012. Prior to joining Sobi Alan held different international executive and general management positions at Amgen, Roche (pharmaceuticals and diagnostics), and Pharmacia. He has also held two CEO positions for venture capital owners within the medical device industry. Alan initially trained and worked as an advanced life support paramedic before graduating from the University of Maryland with a Bachelor of Science Degree in Emergency Health Care Management. He studied for his MBA at the George Washington University in Washington DC. Alan holds Swedish and American citizenship.

Image

Kay-Christian Karstadt

Chief Operating Officer

After graduating from the National Taiwan University in International Business, Kay-Christian led the business unit Oncology and Specialised Therapeutics of Schering AG (Germany) in Taiwan. This company is now part of Bayer Healthcare Pharmaceuticals. During this assignment he and his team were responsible for sales and marketing of several scientifically challenging products and deeply involved with Named Patient as well as Pre-Marketing programs. He then moved on to establish new areas of activity in his capacity as Regional Business Development Manager at Zuellig Pharma Asia Pacific, Hong Kong. He was mainly engaged in storage and distribution across Asia and generating clients for this new business. Since 2009 Kay-Christian has been establishing the activities of the Multipharma Group in the EU, particularly Germany, as well as in Asia. He manages and oversees all global operations, including business development, group financing and controlling, customer service and quality.

Image

Mark Corbett

Executive Vice President,
Medicines Access

Mark is Executive Vice-President of Inceptua Medicines Access. He has over 20 years’ industry experience in the areas of access to unlicensed medicines, Named Patient / Pre-Approval / Early Access / Expanded Access / Managed Access and Compassionate Use Programs.

Previously, he was Managing Director at Idis, Global Access, Senior Vice President at Clinigen Global Access Programs, Head of European Business Development at Idis and an Independent Pharmaceutical Consultant. Mark has extensive specialist knowledge and operational expertise gained through the implementation of more than 150 global programs for a variety of biopharmaceutical companies across all stages of the drug lifecycle.

Image

Peter Reichart

Executive Director Corporate Development

Peter joined Inceptua in 2009 and he has been leading the Finance & Administration department since 2014, where he oversees Finance, HR, Legal, IT and Office Management. His focus at Inceptua has been to set up workflows and to align processes across all Inceptua entities.

Prior to joining Inceptua, Peter worked for service companies as Strategic Marketing Consultant and Director of Client Services. Focusing on digital marketing transformation and innovation, mainly in the field of FMCG, Peter also spent five years in Mexico and Argentina, gaining a deeper understanding of Latin American markets. He holds Bachelor’s and Master’s degrees in Media Production.

Image

Stefan Fraenkel

Executive Vice President, Commercial Products & Services

Stefan Fraenkel (MBA, PhD, Ass. Prof.) is leading Inceputa’s Commercial Products and Services division. Stefan has extensive experience from the pharmaceutical industry. He came to Inceptua from Sobi (Swedish Orphan Biovitrum) where he started in 2009, having held senior management positions in Marketing & Sales, and as Head of Sobi’s Corporate Development and Strategy. Before Sobi, Stefan worked at Wyeth/Pfizer and held international commercial leadership positions both in Europe and in the USA. He also has a background in management consultancy. Stefan holds an MBA degree as well as a PhD degree in international economics from Copenhagen Business School, and a Bachelor of Science degree from Chalmers University of Technology. Stefan has also studied marketing in the USA, both at University of San Diego and at Wharton Business School.

Get in Contact
Please select which
department you wish to
contact
  • Clinical Trials Supply
  • Medicines Access
    • Pharma
    • Healthcare
    • Consulting
  • Clinical Services

enquiries@multipharma.com

Get in contact with us!

medicinesaccess@
inceptua.com

Get in contact with us!

access@inceptua.com

Get in contact with us!

medicinesaccess@
inceptua.com

Get in contact with us!

enquiries@inceptua.com

Get in contact with us!

Preferred response:

PhoneEmail